Caspase-3, the executor in apoptosis, can activate gasdermin E (GSDME/DFNA5) in cancer cells receiving chemotherapy; in contrast, it inactivates GSDMD by cleaving it at D88 sites (destroying the N-terminal pore formation structure) [37,38,39]. The gene discussed is GSDME; the disease is cancer.